21.8 C
Tuesday, September 28, 2021

Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK Paul

India’s indigenously-developed Covid vaccine Covaxin may quickly obtain Emergency Use Listing by the World Health Organisation, finally enabling its recipients to journey overseas with out necessary quarantine, NITI Aayog’s Member, Health, VK Paul stated on Wednesday.

Data sharing and knowledge analysis are occurring and a optimistic resolution may come quickly, he stated.

“The knowledge sharing and knowledge analysis have been occurring by way of a number of opinions and we’re near a call level.

“We must give time to WHO to make their decisions based on science. However, we hope that these decisions can be taken quickly because people who are receiving Covaxin have certain imperatives of travel. Most of us, who chose the concurrency, is important in terms of licensure. We are hoping for an early decision,” Dr Paul stated.

“We believe that a positive decision could be coming in, before the end of the month,” he added.

In August, Indian Health Minister Mansukh Mandaviya additionally met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the WHO approval of Covaxin.

The vaccine’s developer Bharat Biotech has submitted its Phase 3 medical trials knowledge that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

The WHO has to this point accepted Covid-19 vaccines by Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna, and Sinopharm.

#Note-Author Name –

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected

- Advertisement -spot_img

Latest Articles